• N-Formimidoyl Thienamycin vs β-Lactams: 1982 Study

  2026-08-23

  Cullmann and colleagues compared N-formimidoyl thienamycin (MK0787) with several contemporary β-lactam antibiotics across 470 clinical isolates, emphasizing resistant Enterobacteriaceae, nonfermenting gram-negative organisms, and selected gram-positive bacteria. The study showed that MK0787 combined broad antibacterial activity with strong bactericidal behavior against gram-negative isolates and activity that was largely independent of β-lactamase production.

• BMS-777607 Workflow for c-Met Inhibition

  2026-08-22

  BMS-777607 supports a dual research strategy: mechanistic MET signaling pathway inhibition in cancer models and exploratory small-molecule testing in hiPSC-derived megakaryocyte workflows. This guide separates validated product evidence from assay-development recommendations to improve reproducibility, interpretation, and troubleshooting.

• Epalrestat: From Polyol Pathway to Parkinson’s

  2026-08-21

  Epalrestat is an aldose reductase inhibitor with emerging relevance to oxidative stress research and Parkinson’s disease models. This article translates the latest KEAP1/Nrf2 findings into a practical, tiered assay strategy while clarifying material handling and translational limits.

• Ganetespib (STA-9090): Assay Q&A

  2026-08-21

  A scenario-based guide to using Ganetespib (STA-9090), SKU A4385, in cell viability, proliferation, and cytotoxicity workflows. It connects Hsp90 mechanism, solvent handling, exposure design, orthogonal readouts, and vendor-selection criteria to improve interpretation in cancer research.

• Cirsium setidens Protects Against Doxorubicin Cardiotoxicity

  2026-08-20

  A July 2024 Phytomedicine study found that a hydroethanolic extract of Cirsium setidens reduced doxorubicin-associated mitochondrial injury and cardiac dysfunction through an AMPK–PGC-1α–NRF1–SOD pathway. Its use of cardiomyocyte, breast cancer, mouse, and human iPSC-derived cardiac models supports a mechanistically grounded strategy for separating cardioprotection from loss of anticancer activity.

• HPF for Highly Reactive Oxygen Species Detection

  2026-08-20

  HPF (hydroxyphenyl fluorescein) provides a selective green-fluorescence readout for hydroxyl radicals and peroxynitrite in live-cell assays. This guide translates that chemistry into microscopy, plate-reader, flow-cytometry, and multimodal phototherapy workflows, with practical controls and troubleshooting advice.

• L-Alanyl-L-Glutamine for Barrier Assay Workflows

  2026-08-19

  Build more controlled intestinal barrier experiments with a stable, water-soluble L-Ala-L-Gln dipeptide and clearly defined handling steps. The workflow also shows how to use it as a nutritional and cell-state control when adapting antiviral screening concepts without overstating antiviral activity.

• hCG–CXCL10 Regulation by Histone Methylation

  2026-08-19

  Silasi and colleagues show that human chorionic gonadotropin represses CXCL10 in human decidual stromal cells by promoting EZH2-associated H3K27me3 deposition at a defined CXCL10 promoter region. The study connects trophoblast-derived hormonal signaling with chromatin remodeling and CD8 T-cell recruitment, providing a mechanistic framework for epigenetic regulation research at the maternal–fetal interface.

• RSV NS3 Hijacks Signaling to Balance Pathogenicity

  2026-08-18

  Zhuang et al. show that Rice stripe virus NS3 switches between distinct interaction and phosphorylation states to coordinate viral pathogenicity, transmission, and host survival. The study identifies the OsSnRK3.25–OsCBL1/3–OsRBOHF pathway as a regulatory hub linking calcium signaling, reactive oxygen species, programmed cell death, and antiviral RNA interference across rice, planthopper, and wheat systems.

• MEG3, TGF-β, and NiO Nanoparticle Pulmonary Fibrosis

  2026-08-18

  The reference study identifies lncRNA MEG3 as a suppressor of nickel oxide nanoparticle-induced pulmonary fibrosis and links its loss to TGF-β1-driven PI3K/AKT activation. Its combined rat, A549-cell, inhibitor, and gene-overexpression design provides a mechanistic framework for studying how nanoparticle exposure promotes collagen deposition.

• Angiotensin 1/2 (1-6) in RAS Assays

  2026-08-17

  Angiotensin 1/2 (1-6), the Asp-Arg-Val-Tyr-Ile-His hexapeptide, gives researchers a defined input for vascular, renal, and receptor-binding experiments. This guide connects practical handling and dose-response workflows with a recent finding that shorter angiotensin fragments can enhance spike–AXL binding, while clearly separating established evidence from assay-development recommendations.

• Exendin-4 Workflows for Beta Cell Research

  2026-08-16

  Exendin-4, also known as Exenatide, connects receptor-proximal cAMP signaling with functional insulin secretion assays. This guide pairs practical beta cell workflows with a yeast-expression strategy that may improve reagent accessibility for type 2 diabetes research.

• Rapamycin (Sirolimus) Research Workflows

  2026-08-15

  Rapamycin (Sirolimus) offers a precise way to interrogate mTOR-dependent growth, immune activation, differentiation, and metabolic phenotypes. This practical guide connects concentration-controlled assays with a Langerhans cell histiocytosis finding that shows why treatment timing can determine whether mTOR inhibition suppresses or reinforces a disease-associated marker program.

• Salmonella Haem, Phagocytosis, and Virulence

  2026-08-15

  A recent Nature Microbiology study identifies SirM-mediated methylation of HemL as a regulatory mechanism that increases Salmonella haem biosynthesis and suppresses macrophage phagocytosis. The work links bacterial haem production to TLR4-dependent inhibition of Cdc42, macrophage death, and enhanced virulence in mice, extending haem biology beyond iron acquisition.

• Tofacitinib Citrate: Applied JAK3 Workflows

  2026-08-14

  Tofacitinib citrate enables concentration-resolved studies of lymphocyte signaling, cytokine production, and inflammatory endothelial responses. This practical guide combines immune-cell workflows with vascular safety readouts so researchers can separate pathway modulation from cytotoxicity and dose-related artifacts.

451 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page